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Prevalence of cerebral white matter lesions in
elderly people: a population based magnetic
resonance imaging study. The Rotterdam Scan
Study
F-E de Leeuw, J C de Groot, E Achten, M Oudkerk, L M P Ramos, R Heijboer,
A Hofman, J Jolles, J van Gijn, M M B Breteler
Abstract
Objective—White matter lesions are often
seen on MR scans of elderly non-
demented and demented people. They are
attributed to degenerative changes of
small vessels and are implicated in the
pathogenesis of cognitive decline and
dementia. There is evidence that espe-
cially periventricular white matter lesions
are related to cognitive decline, whereas
subcortical white matter lesions may be
related to late onset depression. The
frequency distribution of subcortical and
periventricular white matter lesions ac-
cording to age and sex reported.
Methods—A total of 1077 subjects aged
between 60–90 years were randomly sam-
pled from the general population. All sub-
jects underwent 1.5T MR scanning; white
matter lesions were rated separately for
the subcortical region and the periven-
tricular region.
Results—Of all subjects 8% were com-
pletely free of subcortical white matter
lesions, 20% had no periventricular white
matter lesions, and 5% had no white mat-
ter lesions in either of these locations. The
proportion with white matter lesions in-
creased with age, similarly for men and
women. Women tended to have more sub-
cortical white matter lesions than men
(total volume 1.45 ml v 1.29 ml; p=0.33),
mainly caused by marked diVerences in
the frontal white matter lesion volume
(0.89 ml v 0.70 ml; p=0.08). Periventricu-
lar white matter lesions were also more
frequent among women than men (mean
grade 2.5 v 2.3; p=0.07). Also severe
degrees of subcortical white matter le-
sions were more common in women than
in men (OR 1.1; 95% confidence interval
(95% CI) 0.8–1.5) and periventricular
white matter lesions (OR 1.2; 95% CI 0.9–
1.7), albeit that none of these findings were
statistically significant.
Conclusions—The prevalence and the de-
gree of cerebral white matter lesions
increased with age. Women tended to have
a higher degree of white matter lesions
thanmen. This may underlie the finding of
a higher incidence of dementia in women
than in men, particularly at later age.
(J Neurol Neurosurg Psychiatry 2001;70:9–14)
Keywords: white matter lesions; prevalence; magnetic
resonance imaging; population based
White matter lesions are often found on MR
scans of elderly people, they are attributed to
degenerative changes of long penetrating
arteries.1–6 Reported prevalence ranges from
5% to 90%, depending on study design, study
population, and rating scales.1–3 7–10 There is
evidence that periventricular white matter
lesions are especially related to cognitive
decline,11 whereas subcortical white matter
lesions may be related to late onset depres-
sion.12 White matter lesions can be divided
intothoseinthesubcorticalandthoseintheperi-
ventricular region. Only a few studies consid-
ered lesions in these regions separately,13–15 but
some based their analysis on a summary score
of subcortical and periventricular white matter
lesions,15 as in other studies.1–3 Although it is
well established that the prevalence of white
matter lesions increases with age, little is
known about site specific frequency, including
possible diVerences between the subcortical
and periventricular region and the lobar
location of the lesions. This distinction may
be of potential interest as the subcortical
and periventricular white matter lesions
might have a diVerent pathogenesis and may
result in diVerent cognitive or motor
consequences. Some studies reported a
higher prevalence of white matter lesions
among women then men.1–3 The diVerences
were, however, not statistically significant, and
were only reported for total white matter
lesions.
From a population based sample of subjects
over 60 years of age, we report the age and sex
specific frequency distribution of either type of
white matter lesions by lobar location.
Methods
STUDY POPULATION
The Rotterdam Scan Study was designed to
study determinants and cognitive conse-
quences of age related brain abnormalities in
elderly people. In 1995–6, 1904 normal
healthy subjects aged between 60–90 years
were randomly selected in strata of age
(5 years) and sex from two large ongoing
prospective follow up cohort studies, the
Zoetermeer Study and the Rotterdam Study.
Both studies have been described in detail
elsewhere.16 17 In short, the Zoetermeer Study
is a prospective population based study among
10 361 subjects, aged between 5–91 years at
baseline, which studies determinants of
chronic diseases. The Rotterdam Study is a
population based prospective cohort study,
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among 7983 elderly subjects aged 55 years and
over, which studies determinants of neurologi-
cal, cardiovascular, locomotor, and ophthal-
mological diseases in elderly people.
For the Rotterdam Scan Study subjects were
invited by a letter, and subsequently contacted
by telephone. On agreement to participate a list
of contraindications was reviewed to assess eli-
gibility (dementia; blindness; or presence of
standard MRI contraindications). From 1904
invited subjects 1717 were eligible. Complete
information was obtained, including a cerebral
MR scan, from 1077 persons (response rate
63%; 563 from the Rotterdam Study and 514
from the Zoetermeer Study). Each participant
signed an informed consent form. The study
was approved by the medical ethics committee
of Erasmus University Rotterdam, The Neth-
erlands.
CONFOUNDING VARIABLES
Blood pressure was measured twice on the
right arm in a sitting position, by means of a
random zero sphygmomanometer. The average
of these two measurements was used. Hyper-
tension was defined as a systolic blood pressure
of >160 mm Hg and/or a diastolic blood pres-
sure of >95 mm Hg or the self reported use of
blood pressure lowering drugs. The ankle to
brachial index was used as an indicator of
atherosclerosis and was assessed by taking the
ratio of the systolic blood pressure measured at
the tibial artery to the systolic blood pressure
measured at the right arm with a random zero
sphygmomanometer, in a sitting position.
Information on diabetes mellitus was obtained
with the use of a standardised questionnaire,
which was checked by a physician during the
interview. Diabetes mellitus was considered
present if the participant was taking oral
antidiabetics or insulin.
MR SCANNING PROTOCOL
In all participants an axial T1, T2, and proton
density (PD) weighted cerebral MR scan was
made on a 1.5T MR scan. Subjects recruited
from the Zoetermeer Study were scanned with
a 1.5T MR Gyroscan (Philips, Best, The
Netherlands) and participants from the Rotter-
dam Study were scanned with a 1.5T MR
VISION (Siemens, Erlangen, Germany). To
provide comparability the following pulse
sequences were applied: at the Gyroscan T1
(TR 485 ms, TE 14 ms), T2 (TR 2236, TE 90
ms) and PD (TR 2236 ms, TE 20 ms); and at
the VISION: T1 (TR 700 ms, TE 14 ms), T2
(TR 2200 ms, TE 80 ms) and PD (TR 2200
ms, TE 20 ms) Slice thickness was 6 mm and 5
mm respectively, with an interslice gap of
20.0%. The images were printed on hard copy
with a reduction factor of 2.7.
WHITE MATTER LESIONS RATING SCALE
White matter lesions were considered present if
these were hyperintense on both PD and T2
weighted images and not hypointense on T1
weighted images. White matter lesions were
classified into those in the subcortical and
periventricular region.11 The number and size
of subcortical white matter lesions was rated on
hard copy according to the largest diameter of
one lesion within all slices in which the lesion
could be seen in categories of small (<3 mm),
medium (3–10 mm), or large lesions (>10
mm). To calculate the volume of subcortical
white matter lesions on hard copy, they were
considered to be spherical with a fixed
diameter per size category (range 0–29.5 ml).
Periventricular white matter lesions were rated
semiquantitatively per region: adjacent to fron-
tal horn (frontal capping), adjacent to lateral
wall of lateral ventricles (bands), and adjacent
to occipital horn (occipital capping) on a scale
of 0 (no white matter lesions), 1 (pencil thin
periventricular lining), 2 (smooth halo or thick
lining), or 3 (large confluent white matter
lesions). This was done for both hemispheres
simultaneously. The overall degree of periven-
tricular white matter lesions was calculated by
adding up the scores for the three separate cat-
egories (range 0–9). White matter lesions could
be rated for all subjects except in two in whom
the quality of the MR scan did not allow
reliable rating of the subcortical white matter
lesions. All MR scans were examined by two
raters who were blinded to age, sex, and other
risk factors for white lesions. In case of a disa-
greement of more than one point, a consensus
reading was held; in all other cases the readings
of both readers were averaged. The interrater
and intrarater studies showed a good to excel-
lent agreement. For grading the periventricular
white matter ê values were calculated by taking
into account the diVerence between the scores
of the two raters. These so called weighted ê
values were between 0.79–0.90. For total sub-
cortical white matter volume the interrater and
intrarater intraclass correlation coeYcient was
0.88 and 0.95, respectively.
STATISTICAL ANALYSIS
The prevalence of white matter lesions was
defined as the presence of any white matter
lesion (regardless of size or location) in the
brain. The relation between the prevalence of
white matter lesions and age was assessed by
means of age and sex adjusted linear regression
analyses. The frequency distribution of either
type of white matter lesions was calculated by
10 years age strata (60–70, 70–80, and 80–90
years). The relation between sex and white
matter lesions was assessed by means of age
adjusted linear regression with white matter
lesions as the dependent variable. Analysis of
covariance (ANCOVA) was performed to
obtain sex specific mean volume of subcortical
white matter lesions per 10 year age stratum or
the mean grade of the periventricular white
matter lesions. Sex diVerences for each cat-
egory (0, 1, 2, and 3) of periventricular white
matter lesions per region, were analyzed with
the ÷2 test. There is increasing evidence that
there exists a dose dependent relation between
severity of white matter lesions and cognitive
consequences.1 2 and that especially the pres-
ence of severe white matter lesions is associated
with a reduced cognitive function.11 18 We
therefore separately analyzed severe subcortical
and periventricular white matter lesions for
each sex by means of an age adjusted logistic
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regression model. White matter lesions were
dichotomised at the upper quintile of their dis-
tribution, which reflects severe white matter
lesions. The associations are presented as odds
ratios with a 95% confidence interval (OR;
95%CI).
Results
The overall response rate was 63%; it
decreased with age from 73% in subjects aged
between 60–70 years to 48% in participants
aged between 80–90 years. Responders were
therefore significantly younger than non-
responders (mean age 72.4 years v 75.9 years,
p<0.001), whereas there was no sex diVer-
ence.
In our study 8% of all subjects were
completely free of subcortical white matter
lesions, 20% had no periventricular white mat-
ter lesions and 5% had no white matter lesions
in either of these locations. Frequency distribu-
tion of white matter lesions at both locations
strongly depended on age (figs 1 and 2). Of
subjects aged between 60–70 years, about 13%
were completely free of subcortical white mat-
ter lesions and 32% were free of periventricular
matter lesions, whereas for subjects aged
between 80–90 years these percentages were 0
and 5, respectively. The relation between age
and the prevalence of white matter lesions was
similar for men and women. The prevalence of
subcortical and periventricular white matter
lesions significantly increased, by 0.2% and
0.4% per year, respectively. Possible confound-
ing variables including hypertension, diabetes,
and indicators of atherosclerosis were equally
distributed between men and women. Adjust-
ment for these factors did not alter the magni-
tude of the associations presented below.
Table 1 shows the volume of subcortical
white matter lesions/10 year age stratum by
sex. The mean volume of subcortical white
matter lesions was highest in the frontal lobe,
followed by the parietal, occipital, and tempo-
ral lobes. This applied to both sexes and all age
groups. The mean volume of subcortical white
matter lesions increased from 0.6 ml (SE 0.1)
for subjects between 60–70 years of age to 3.2
ml (SE 0.4) for subjects aged between 80–90
years (p<0.01). Women had greater volumes of
subcortical white matter lesions than men
(total volume 1.45 ml v 1.29), mainly caused
by diVerences in the volume of frontal white
matter lesions (0.89 ml v 0.70), but these
diVerences were not significant (p=0.33 and
p=0.08, respectively).
Table 2 shows sex specific mean grades of
periventricular white matter lesions/10 year
category. The mean grade of periventricular
Figure 1 Distribution of subcortical white matter lesions
by 10 year age category.
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Figure 2 Distribution of periventricular white matter
lesions by 10 year age category.
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Table 1 Mean volume (ml) of subcortical white matter lesions/lobar location/10 y age stratum†
Lobar location
60–70 y (n=464) 70–80 y (n=415) 80–90 y (n=196) Overall (n=1075)
Men
(n=226)
Women
(n=238)
Men
(n=203)
Women
(n=212)
Men
(n=92)
Women
(n=104)
Men
(n=521)
Women
(n=554)
Frontal 0.23 (0.06) 0.43 (0.06)* 0.75 (0.12) 0.90 (0.12) 1.73 (0.31) 1.87 (0.29) 0.70 (0.08) 0.89 (0.07)
Parietal 0.25 (0.05) 0.26 (0.05) 0.50 (0.07) 0.45 (0.06) 1.25 (0.17) 1.23 (0.17) 0.53 (0.05) 0.51 (0.04)
Occipital 0.01 (0.01) 0.02 (0.01) 0.05 (0.02) 0.02 (0.02) 0.16 (0.05) 0.12 (0.04) 0.05 (0.01) 0.04 (0.01)
Temporal 0.00 (0.00) 0.00 (0.00) 0.01 (0.02) 0.00 (0.00) 0.05 (0.02) 0.02 (0.02) 0.01 (0.00) 0.01 (0.00)
Whole brain 0.49 (0.10) 0.72 (0.10) 1.31 (0.18) 1.38 (0.18) 3.18 (0.48) 3.31 (0.44) 1.29 (0.12) 1.45 (0.12)
*p<0.05.
†Expressed as mean ml white matter lesion volume on hard copy (SE).
Table 2 Sex specific mean grade of periventricular white matter lesions/ region/10 y age stratum†
Lobar location
60–70 y(n=465) 70–80 y (n=416) 80–90 y (n=196) Overall (n=1077)
Men
(n=226)
Women
(n=239)
Men
(n=204)
Women
(n=212)
Men
(n=92)
Women
(n=104)
Men
(n=522)
Women
(n=555)
Frontal capping 0.5 (0.0) 0.6 (0.0)* 0.8 (0.1) 1.0 (0.1)** 1.3 (0.1) 1.5 (0.1)* 0.8 (0.0) 0.9 (0.0)**
Bands 0.6 (0.0) 0.5 (0.0) 0.9 (0.1) 1.0 (0.1) 1.4 (0.1) 1.5 (0.1) 0.8 (0.0) 0.9 (0.0)
Occipital capping 0.3 (0.1) 0.3 (0.1) 0.7 (0.1) 0.8 (0.1) 1.4 (0.1) 1.4 (0.1) 0.7 (0.0) 0.7 (0.0)
Total periventricular 1.4 (0.1) 1.5 (0.1) 2.4 (0.1) 2.8 (0.1) 4.1 (0.2) 4.4 (0.2) 2.3 (0.1) 2.5 (0.1)
*p<0.05; **p<0.01.
†Expressed as mean grade (SE).
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white matter lesions increased from 1.5 (SE
0.1) for subjects between 60–70 years of age to
2.4 (SE 0.1) for subjects aged between 80–90
years (p<0.01). The mean grade of the total
periventricular white matter lesions was non-
significantly higher among women than men
(2.5 (SE 0.1) v 2.3 (SE 0.1); p=0.07), mainly
caused by the significant diVerence in severity
of frontal capping between men and women in
all age categories.
Table 3 shows the proportion of subjects
with diVerent degrees of periventricular white
matter lesions for each of the three diVerent
locations per 10 year age stratum. For all age
categories and at every location, proportionally
more women than men had the most severe
periventricular white matter lesions.
Women had more severe periventricular (OR
1.2; 95% CI 0.9–1.7) and subcortical white
matter lesions (OR 1.1; 95% CI 0.8–1.5) than
men, especially in the frontal region (OR 1.6;
95% CI 1.2–2.1 and OR 1.6; 95% CI 1.2–2.2,
for severe frontal periventricular and subcorti-
cal white matter lesions, respectively).
Discussion
Our study shows that the severity of subcortical
and periventricular white matter lesions is
dependent on age and sex. We confirmed the
significant association between severity of
white matter lesions and age. In addition we
found that women tended to more often have
white matter lesions of both kinds, especially in
the frontal region.
The strength of this study is its large number
of elderly people, including persons in institu-
tions. Another important feature of our study is
the distinction between white matter lesions in
the subcortical and the periventricular region,
and according to lobe.
However, some potential methodological
shortcomings need to be considered. Our study
had a response rate of 73% in subjects aged
60–70 years decreasing to 48% in participants
aged between 80–90 years. This may lead to
selection bias, especially in the oldest age
category. We consider it likely that if participa-
tion in our study were related to the degree of
white matter lesions, this would probably have
resulted in persons with more severe white
matter lesions participating less. Therefore the
mean volume of subcortical white matter
lesions and the mean grade of periventricular
white matter lesions has probably been under-
estimated. This particularly applies to the old-
est participants, among whom the response
was lowest. However, we consider it unlikely
that the sex diVerence for white matter lesions
has been influenced by selection bias, as the
response rate was similar for men and women
in any age category.
Another point of concern is the validity of
the white matter lesion rating scale, as there is
potential for measurement error in this
procedure. Although we chose anatomical
landmarks to separate the lobes we cannot
exclude the possibility that some misclassifica-
tion occurred. As it is unlikely that this
misclassification would be diVerent for the
sexes or age categories, the resulting bias will
be non-diVerential. When subcortical and
periventricular white matter lesions are both
abundantly present, it may sometimes be
diYcult to distinguish between the two. How-
ever, our intrarater and interrater studies
showed an excellent to high reliability, suggest-
ing that this was not a major problem in our
study.
An important aspect of our rating scale is
that it distinguishes between subcortical and
periventricular white matter lesions while their
severity was also recorded. This will allow us to
evaluate whether white matter lesions in these
two regions have a diVerent pathogenetic back-
ground and diVerent clinical correlates.
Our study showed that subcortical white
matter lesion volume was highest in the frontal
and parietal lobes, 20 and 100 times higher
than in the occipital and temporal lobes,
respectively. Although the frontal and parietal
lobes are larger than the occipital and the tem-
poral lobes, this diVerence cannot explain the
vast diVerence in white matter lesion volume.
Scheltens et al found in a study of 24 “normal”
elderly subjects (mean age 68.0 years) that the
severity of white matter lesions was highest in
the frontal lobe.19 This finding was even more
marked in subjects with Alzheimer’s disease.
They explained this finding by overrepresenta-
tion of the frontal and parietal lobe compared
with the occipital and the temporal lobe axial
slices.19 We cannot exclude the possibility that
Table 3 Sex specific frequency distribution of periventricular white matter lesions grades/ region/10 y age stratum
Location Grade
60–70 y 70–80 y 80–90 y Overall
Men
(n=226)
Women
(n=239)
Men
(n=204)
Women
(n=212)
Men
(n=92)
Women
(n=104)
Men
(n=522)
Women
(n=555)
Frontal capping 0 50.0 42.2 29.9 22.9 14.9 8.5 35.9 28.5
1 40.6 41.9 43.1 42.0 39.4 31.1 41.4 39.8
2 8.9 14.6 25.5 33.2 40.4 51.9 21.0 28.8
3 0.5 1.3 1.5 1.9 5.3 8.5 1.7 2.9*
Bands 0 43.8 46.2 27.0 25.7 8.5 10.4 30.9 31.6
1 45.6 43.8 51.0 45.8 43.6 35.8 47.3 43.1
2 9.7 8.3 18.6 21.0 30.9 34.9 17.0 18.2
3 0.9 1.7 3.4 7.5 17.0 18.9 4.8 7.1
Occipital capping 0 71.7 72.4 48.2 42.5 25.6 23.0 54.2 51.8
1 20.8 18.8 27.9 32.7 22.6 29.5 23.9 26.1
2 6.2 7.1 18.1 17.8 34.4 25.8 15.8 14.6
3 1.3 1.7 5.8 7.0 17.4 21.7 6.1 7.5
Numbers are percentages.
*p=0.005 (Overall ÷2 test).
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we have relatively overestimated the frontal or
parietal lobes, but again the magnitude of the
diVerence in the volume of white matter
lesions seems out of proportion to this. We are
not aware of any diVerence in vascularisation
between the lobes that might explain the large
interlobe diVerence in the prevalence of white
matter lesions.
Our study confirms previous findings of a
relatively high prevalence and severity of white
matter lesions among women.1 This was also
found in the Cardiovascular Health Study and
the Atherosclerosis Risk in Communities
Study.2 3 This could be mainly attributed to
the significant diVerences for the subcortical
and periventricular white matter lesions in the
frontal region. The higher prevalence of white
matter lesions among women was in accord-
ance with magnetic resonance spectroscopy
studies that were done in the Rotterdam Study
part of our study population. We found an
increased variance in the ratio between
choline, creatinine, and N-acetyl aspartate
concentrations in the frontal periventricular
region, and concentrations of those metabo-
lites in the whole brain in women compared
with men, which may be compatible with the
finding of an increased prevalence of white
matter lesions in women.20 It is unclear how
these sex diVerences must be explained. One
possibility is an increased susceptibility for
ischaemia of the brain secondary to the reduc-
tion in estrogen concentrations after meno-
pause plays a part. The occurrence of hypoxia
or ischaemia in the cerebral white matter is
commonly considered as an intermediate
factor in the pathogenesis of white matter
lesions.6 Estrogens have important functions
in the brain, including an increase in cerebral
blood flow, protection against oxidative
stress, stimulation of synaptogenesis, and pre-
vention of neuronal atrophy.21–23 The post-
menopausal estrogen reduction might make
the female brain more vulnerable by reduction
of cerebral blood flow (ischaemia) and impair-
ment of neuronal repair mechanisms. This
hypothesis is supported by in vitro studies,
which showed protective eVects of estrogens
on menopause related cerebral damage by
excitotoxicity and the action of free radicals, as
occurs during cerebral ischaemia.24–28 As there
is a morphological and epidemiological over-
lap between vascular dementia and
Alzheimer’s disease, the increased prevalence
of cerebral white matter lesions in women
could underlie the higher incidence of
Alzheimer’s disease among women, even after
adjustment for prolonged life expectancy,
especially at high ages.29 This hypothesis,
which we did not attempt to test in this study,
about the possible role of estrogens is
supported by the finding of a significantly
increased incidence of Alzheimer’s disease
among women who did not use estrogen
replacement therapy.30 31
In conclusion, prevalence of cerebral white
matter lesions increased with age. Women
tended to have more often severe white matter
lesions compared with men, especially in the
frontal region. Large prospective population
based studies are needed to investigate what
underlies these diVerences and in particular to
which factors play a part in the presence and
development of white matter lesions and the
attendant cognitive decline.
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HISTORICAL NOTE
Saint Vitus and his dance
In the current nomenclature Saint Vitus’
dance or chorea (from the Greek ÷ïñåíá for
dance) has been largely displaced by the epo-
nym Sydenham‘s chorea. The exchange
occurred recently, although the association of
the saint and his dance had a long evolution.
It attested to the durability of the cult of Saint
Vitus in which the early notions of the dance
underwent diVerentiation by physicians cen-
turies later.
The legend and tradition
According to hagiographic texts, Saint Vitus
or Guy was born during the third century in
Sicily, southern Italy.1 2 He came from an
illustrious family and against the wishes of
family and teachers he became a Christian.
During a brief career Vitus was said to have
performed numerous miracles.3 On one
occasion he cured the paralysis of the hands
of his tormentors. On another, his father lost
his sight on seeing angels in front of his son.
Vitus prayed for him, whereupon his father
regained his vision. In another episode the
saint relieved the son of the emperor Diocle-
tianus of his demons, by laying his hands over
the head. These miraculous feats contributed
to the making of Vitus’ later reputation as the
patron saint of neurological disorders. It was
the same Diocletianus who had Vitus, still a
boy, put to death in 303. Vitus’ iconography
included many depictions of him, inside or
holding a boiling cauldron, the symbol of his
martyrdom. Afterwards his relics were trans-
ported to Paris and Prague. His cult grew
with the establishment of many chapels of
Saint Vitus throughout Europe. Veneration of
the saint appeared particularly strong among
the Germans, Czechs, and Slavs who sought
his cure of hydrophobia and other illnesses.4
The association with chorea
The healing power of the saint’s relics was
thought to be especially eYcacious for the
sick with “unsteady step, trembling limbs,
limping knees, bent fingers and hands,
paralysed hands, lameness, crookedness, and
withering body”.3 5 The signs and symptoms
in this grouping mimicked the movements of
a dance, and thus the linkage of Vitus and his
dance acquired a popular coinage. As the
clinical features were heterogeneous, Saint
Vitus’ dance (also known as triste mal)
became an umbrella term for an assortment
of conditions with movement disorder. The
association was further enhanced during the
middle ages when outbreaks of dancing
mania and other delirious behaviour struck
Europe. Pieter Brueghel the Elder in 1564
depicted the mania of Saint Vitus’ dance in a
well known print entitled “Procession of the
Possessed”, reproduced in Schechter.6 The
explanation of these historical events re-
mains unclear. Whether they represented
mass hysteria, epidemic infection, or food
poisoning has not been resolved. The
identification of these epidemics with the
present day Sydenham’s chorea is also prob-
lematic. However, the dance did undergo a
process of diVerentiation. In the 16th
century Paracelsus designated Saint Vitus’
dance as “chorea naturalis”. He recognised
that the loss of emotional stability and
voluntary motor control was central in the
course of the disease.7 A century later
Sydenham, in 1686, clarified the kinetic dis-
turbances:
“ . . .Saint Vitus’ dance is a sort of
convulsion which attacks boys and girls
from the tenth year till they have done
growing. At first it shows itself by a halt-
ing, or rather an unsteady movement of
one of the legs, which the patient drags.
Then it is seen in the hand of the same
side. The patient cannot keep it a
moment in its place, whether he lay it
upon his breast or any other part of his
body. Do what he may, it will be jerked
elsewhere convulsively . . ..”6
Sydenham also described rheumatic fever
with its articular manifestations, but he failed
to connect it with the chorea. The failure was
due in part to the fact that Sydenham and his
colleagues did not have a clear idea of the vis-
ceral involvement in rheumatic fever. The
lack of an auscultation method undoubtedly
hampered Sydenham in making the diagnosis
of rheumatic carditis. It remained for Richard
Bright in 1831 to make the linkage:
“The instances of the combination and
alteration of rheumatism and chorea are
very numerous; and though I doubt not,
in some cases the coverings of the
cerebrospinal mass may be and are impli-
cated, yet I believe that the much more
frequent cause of chorea, in conjunction
with rheumatism, is the inflammation of
the pericardium. The irritation probably
is communicated thence to the spine . . ..”6
We have here the chorea, the peripheral, and
systemic manifestations of rheumatic fever
grouped together for the first time. Others,
notably See in 1850, also articulated the uri-
nary view, that the chorea, carditis, and the
articular features were all components of the
rheumatic fever.6 Bright could not be faulted
for a misguided notion of the disease
pathogenesis, for it was not until the 1930s
that the infectious process in rheumatic fever
was elucidated by the work of A F Coburn,
among others.8 The cerebral lesion of chorea
and its relation to the damage in other organs
remain unresolved issues. Nevertheless, we
have advanced far in our understanding of
Saint Vitus’ dance, or in modern usage,
Sydenham’s chorea.
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